HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Endocrine disruptors

This article was originally published in The Rose Sheet

Executive Summary

Endocrine disruptors: National Toxicology Program holding meeting on endocrine disruptor initiatives May 14, NTP announced in an April 30 Federal Register notice. The board plans to review NTP and National Institute of Environmental Health Sciences' studies on the toxicity and carcinogenicity of endocrine disruptors. Endocrine disruptors, or modulators, are believed to alter growth and development of the endocrine system. The Cosmetic, Toiletry and Fragrance Association has been following the issue, but said it is "unlikely" it will attend the hearing. The trade group said industry and the government need to first determine if endocrine modulators have any effect on humans and then consider appropriate testing methods for products. The Environmental Protection Agency is dedicating $30-$50 mil. to investigate testing methods, according to CTFA. The NTP meeting will taken place at NIEHS, Conference Center, Building 101, South Campus at 8:45 a.m. in Research Triangle Park, N.C...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004111

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel